![Aussie Judge Susan Hoevenaars Reports "Complete Success" of Surgery for Early Stage Breast Cancer - Dressage-News Aussie Judge Susan Hoevenaars Reports "Complete Success" of Surgery for Early Stage Breast Cancer - Dressage-News](http://www.dressage-news.com/wp-content/uploads/2016/12/SusieHooevanars.jpg)
Aussie Judge Susan Hoevenaars Reports "Complete Success" of Surgery for Early Stage Breast Cancer - Dressage-News
![Study Suggests Partial Breast Radiation Sufficient for Early Breast Cancer | Imaging Technology News Study Suggests Partial Breast Radiation Sufficient for Early Breast Cancer | Imaging Technology News](http://www.itnonline.com/sites/default/files/Mammogram%20with%20tumor_Vendor%20supplied%20by%20Barco_3.jpg)
Study Suggests Partial Breast Radiation Sufficient for Early Breast Cancer | Imaging Technology News
ESOI - European Society of Oncologic Imaging - We are very proud to announce that ESOI is now the newest member of ECCO - the European CanCer Organisation! ECCO's vision is to
![Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting](https://mma.prnewswire.com/media/1762876/3912638/Oncolytics_Biotech_New_Logo.jpg?p=twitter)
Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting
We are proud to have Professor Krishna Clough among 12th BGIICC Board . Professor CLOUGH is one of the most renowned international experts in the domain of breast surgery. He is known
![Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial | Nature Medicine Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-019-0432-4/MediaObjects/41591_2019_432_Fig1_HTML.png)
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial | Nature Medicine
![Frontiers | The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis Frontiers | The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/575272/575272_Thumb_400.jpg)
Frontiers | The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis
![Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab - ScienceDirect Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842823001774-ga1.jpg)